Duncan Wheatley, MD, Royal Cornwall Hospital Cancer Centre, Truro, UK, discusses a Phase III, randomized, FAST-Forward trial (NCT04148586). This study aimed to investigate the use of a 1-week course of curative whole breast radiotherapy against a standard 3-week schedule without reducing the beneficial effects of radiotherapy in patients with early breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).